Home | Product No Longer Available place holder

Product No Longer Available


This product Phosphodiesterases is not longer available for purchase.

You may find what you're looking for in the following list of products.


place holder place holder place holder place holder place holder place holder place holder place holder

Results for 'Phosphodiesterases'

Title Sort Publication Date Sort Price Sort Relevance Sort
place holder


Competitive Outlook on Antiangiogenesis and Vascular Targeting in Oncology

 October 2006 £1325 23.45 %
Competitive Outlook on Apoptosis in Oncology

 December 2006 £1325 20.65 %
Triple Analysis: Apoptosis Agents, Protein Kinase Inhibitors and Anti-Angiogenic Agents in Oncology

 December 2006 £3510 17.5 %
Textbook of Interventional Cardiovascular Pharmacology

 April 2007 £140 15.4 %
Rheumatoid Arthritis: Emerging drug discovery targets
And therapeutic candidates

 October 2003 £375 15.4 %
Altana Pharmaceutical Company Intelligence Report

 August 2006 £795 15 %
Triple Analysis: Non Small Cell Lung Cancer, Protein Kinase Inhibitors & Anti-Angiogenic Agents

 October 2006 £2340 14.35 %
Asthma Therapeutics
New treatment options and emerging drug discovery targets

 April 2003 £330 14.35 %
Therapeutics for Inflammatory Diseases
Current Challenges and Future Market

 March 2006 £2410 13.3 %
Targeted Therapies in Oncology
A World Review

 December 2006 £3360 12.95 %
Lead Optimization Strategies
An analysis of novel molecular targets to develop innovative new therapeutics

 January 2005 £1495 11.9 %
Triple Analysis: Apoptosis Agents, Antibodies and Vaccines in Oncology

 December 2006 £2340 11.55 %
Inflammatory Disease Therapeutics
Pipelines and Competitive Dynamics

 June 2005 £2140 10.5 %
Enzyme Inhibitors with Broad Therapeutic Applications

 June 2006 £2410 9.8 %
Novel Targets in Drug Discovery
A new era in therapy

 April 2004 £595 8.4 %
Nitric Oxide
Therapeutics, Markets and Companies

 March 2008 £1390 7.7 %
Stakeholder Opinion: Atopic Dermatitis
A high level of unmet need creates market opportunities

 March 2007 £2000 6.3 %
Cell Therapy
New Drugs, Markets and Companies

 March 2008 £1515 3.15 %
Neuroprotection
Drugs, Markets and Companies

 March 2008 £1740 3.15 %
place holder